SHAREHOLDER ALERT: WeissLaw LLP Reminds CSLT, TMX, ARNA, and MIME Shareholders About Its Ongoing Investigations

<br /> SHAREHOLDER ALERT: WeissLaw LLP Reminds CSLT, TMX, ARNA, and MIME Shareholders About Its Ongoing Investigations<br />

PR Newswire


NEW YORK

,

Jan. 12, 2022

/PRNewswire/ —



If you own shares in any of the companies listed above and

would like to discuss our investigations or have any questions concerning

this notice or your rights or interests, please contact:



Joshua Rubin, Esq.



WeissLaw LLP

305 Broadway, 7th Floor


New York, NY

10007


(212) 682-3025



(888) 593-4771



[email protected]



Castlight Health, Inc

(NYSE: CSLT)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of

Castlight Health, Inc

(NYSE: CSLT), in connection with the proposed acquisition of CSLT by Vera Whole Health, Inc. via a tender offer.  Under the terms of the acquisition agreement, CSLT shareholders will receive

$2.05

in cash for each share of CSLT common stock that they hold. If you own CSLT shares and wish to discuss this investigation or your rights, please call us or visit our website:

https://www.weisslaw.co/news-and-cases/cslt


Terminix Global Holdings, Inc.

(NYSE: TMX)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of

Terminix Global Holdings, Inc.

(NYSE: TMX), in connection with the proposed acquisition of TMX by Rentokil Initial plc (“Rentokil Initial”).  Under the terms of the merger agreement, TMX shareholders will receive approximately 643.29 million new Rentokil Initial shares (representing approximately 128.66 million American depository shares (“ADSs”), based on a 1:5 ADS to Rentokil Initial share ratio) and approximately

$1.3 billion

in cash. If you own TMX shares and wish to discuss this investigation or your rights, please call us or visit our website:

https://www.weisslaw.co/news-and-cases/tmx


Arena Pharmaceuticals, Inc.

(NASDAQ: ARNA)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of

Arena Pharmaceuticals, Inc.

(NASDAQ: ARNA), in connection with the proposed acquisition of the company by Pfizer Inc.  Under the terms of the merger agreement, ARNA shareholders will receive

$100.00

in cash for each share of ARNA common stock that they hold.  If you own ARNA shares and wish to discuss this investigation or your rights, please call us or visit our website:

https://www.weisslaw.co/news-and-cases/arna


Mimecast Limited

(NASDAQ: MIME)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of

Mimecast Limited

(NASDAQ: MIME), in connection with the proposed acquisition of MIME by Permira.  Pursuant to the merger agreement, MIME shareholders will receive

$80.00

in cash for each share of MIME common stock that they hold.  If you own MIME shares and wish to discuss this investigation or your rights, please call us or visit our website:

https://www.weisslaw.co/news-and-cases/mime

Cision
View original content to download multimedia:

https://www.prnewswire.com/news-releases/shareholder-alert-weisslaw-llp-reminds-cslt-tmx-arna-and-mime-shareholders-about-its-ongoing-investigations-301460019.html

SOURCE WeissLaw LLP